US FDA Approves Lupin Pharma’s Generic SOLODYN Tablets

by Savitha C Muppala on  December 2, 2011 at 8:38 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Lupin Pharmaceuticals has received the nod from the US FDA for its Minocycline hydrochloride extended release tablets 45 mg, 55 mg, 90 mg and 135 mg strengths.
 US FDA Approves Lupin Pharma’s Generic SOLODYN Tablets
US FDA Approves Lupin Pharma’s Generic SOLODYN Tablets

Lupin has also received tentative approval for its Minocycline HCI extended release tablets 65 mg, 80 mg, 105 mg and 115 mg strengths.

Solodyn is an oral antibiotic used in the treatment of red, pus-filled pimples and  acne in patients 12 years of age and older.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive